Cabotegravir (Apretude) for Pre-exposure Prophylaxis for HIV Type 1 Infection.
Where this comes from
- Record sourced from PubMed, PMID 37192084.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Cabotegravir (Apretude) is an extended-release injectable HIV type 1 (HIV-1) antiretroviral integrase strand transfer inhibitor. Cabotegravir is labeled for use in adults and adolescents weighing at least 35 kg (77 lb) who are HIV-negative but at risk of HIV-1. It is used as pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 infection, the most common form of HIV.1.
Medical subject headings
- Pre-Exposure Prophylaxis
- HIV Infections
- HIV-1
- Anti-HIV Agents